|
Thursday, April 28, 2005
Actimis Pharmaceuticals Gets $6M
San Diego-based Actimis Pharmaceuticals said this morning that it has closed a $6M Series A financing round from Sanderling VEntures and Mitsui & Co. The company is a spinout of Bayer HealthCare AG, and is developing and commercializing small molecule therapeutics for respiratory and inflammatory diseases. The company said that Bayer HealthCare Ag has assigned the rights to five preclinical research programs to Actimis. The company's technology is applicable for asthma, chronic obstructive pulmonary disease, atopic dermatitis, rheumatoid arthritis, psoriasis and others.
posted on Thursday, April 28, 2005 (Link to more information)
|
 RSS
 Email
Twitter
Previous news:
Tuesday, January 6, 2009
Monday, January 5, 2009
Friday, January 2, 2009
Wednesday, December 31, 2008
Tuesday, December 30, 2008
|
